Karyopharm Therapeutics Inc.
KPTIQ· OTC
Released Aug 6, 2019, before the open
10-Q filed Aug 7, 2019, 38 days after period end · 0001193125-19-215344
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Revenue | $9.49M | $19.89M | $3.00K | $59.00K |
| Net Income | -$43.42M | -$33.66M | -$29.39M | -$30.16M |
| EPS Diluted |
Karyopharm Therapeutics Inc. · CIK 1503802 · Engraved from SEC EDGAR
| -$0.71 |
| -$0.60 |
| -$0.64 |
| -$0.84 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.